4.7 Article

Cryptococcus gattii in AIDS patients, southern California

Journal

EMERGING INFECTIOUS DISEASES
Volume 11, Issue 11, Pages 1686-1692

Publisher

CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid1111.040875

Keywords

-

Funding

  1. NIAID NIH HHS [AI 41968, AI 53732, AI 48462, R01 AI048462, R03 AI053732] Funding Source: Medline

Ask authors/readers for more resources

Cryptococcus isolates from AIDS patients in southern California were characterized by molecular analyses. Pheromone MF alpha 1 and MF alpha 1 gene fragments were polymerase chain reaction-amplified with fluorescently labeled primers and analyzed by capillary electrophoresis (CE) on DNA analyzer. CE-fragment-length analyses (CE-FLAs) and CE-single-strand conformation polymorphisms (CESSCPs) were used to determine Cryptococcus gattii (Cg), C. neoformans (Cn) varieties neoformans (CnVN) and grubii (CnVG), mating types, and hybrids. Corroborative tests carried out in parallel included growth on specialized media and serotyping with a commercial kit. All 276 clinical strains tested as haploid MAT alpha by CE-FLA. CE-SSCP analyses of MF alpha 1 showed 219 (79.3%) CnVG, 23 (8.3%) CnVN, and 34 (12.3%) Cg isolates. CE-FLA and CE-SSCP are promising tools for high-throughput screening of Ctyptococcus isolates. The high prevalence of Cg was noteworthy, in view of its sporadic reports from AIDS patients in North America and its recent emergence as a primary pathogen on Vancouver Island, Canada.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available